• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.


University of Manitoba Health Sciences Center (St. Boniface)



Contact This Member

Gloria Vazquez-Grande

Gloria Vazquez-Grande is a physician in the Department of Internal Medicine at University of Manitoba

I am a Critical Care specialist from Spain who came to Canada in 2014 to pursue additional research training.
I completed my Critical Care Specialty at Hospital Universitario Puerta de Hierro (Universidad Autonoma de Madrid). Critical Care in Spain is a full primary specialty (no background specialty), it is a 5-year program with a mixed training between Medicine and Anesthesia and 2.5 years in Critical Care.

After finishing my Critical Care residency, I worked as an attending physician at Hospital Universitario de Getafe, with Dr. Andres Esteban’s group. Currently I am working at University of Manitoba.

I completed my Master of Science in Medicine at Universidad Autonoma de Madrid in 2013 and I am currently completing a PhD in Medical Microbiology at University of Manitoba under Dr. Anand Kumar’s supervision.
I have joined Drs. Zarychanski, Kumar and Fergusson in the HALO International Trial. Where I will facilitate international collaboration and will serve as a liaison with Spanish speaking colleagues and sites participating in the HALO clinical trial.